(RTTNews) - Fresenius SE & Co. KGaA (FRE.DE), a health care company, on Thursday announced that it has acquired the remaining 45% stake in mAbxience Holding S.L. for up to 750 million euros.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.